Bilirubin Prevents the TH(+) Dopaminergic Neuron Loss in a Parkinson’s Disease Model by Acting on TNF-α

Parkinson’s disease (PD), the fastest-growing movement disorder, is still challenged by the unavailability of disease-modifying therapy. Mildly elevated levels of unconjugated bilirubin (UCB, PubChem CID 5280352) have been shown to be protective against several extra-CNS diseases, and the effect is...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayanti, Sri, Moretti, Rita, Tiribelli, Claudio, Gazzin, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693357/
https://www.ncbi.nlm.nih.gov/pubmed/36430754
http://dx.doi.org/10.3390/ijms232214276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693357/
https://www.ncbi.nlm.nih.gov/pubmed/36430754
http://dx.doi.org/10.3390/ijms232214276

Ejemplares similares